3D Cell Culture Market Overview and Introduction

3D cell culture market is estimated to be over US$ 600.0 Mn in 2017. It is anticipated to grow at a CAGR of 19.8% from 2019 to 2030.

3D cell culture involves artificially growing biological cells in all three surrounding directions. In 3D cell culture, the cells are grown in in-vitro conditions which in turn mimics in-vivo conditions. Three dimensional cultures in most cases are grown in bioreactors or capsules, where the cells grow in the form of spheroids.

Advent of new techniques, namely scaffold-free systems utilized for translational pathway development for tissue have been extremely crucial in incrementing the demand for 3D cell culture market in recent times. Moreover, increasing R&D investments & funding from both private and public sector in the field of cell-based research has played a significant role in increasing the demand for such products. However, lack of infrastructure for research in relation to 3D cell culture is anticipated to restrain the growth of the market to a certain extent.

3D Cell Culture Market by Product

On the basis of product, the 3D cell culture market is segmented into scaffold-based 3D cell culture, scaffold-free cell culture, magnetic levitation & 3D bioprinting, and microfluidics-based 3D cell culture. The scaffold-based 3D cell culture segment is further classified into hydrogels/ECM analogs, micropatterned surfaces and solid scaffolds. Whereas, the segment of scaffold-free cell culture can be bifurcated into low-adhesion microplates, 3D bioreactors, hanging drop plates and 3D petri dishes. In terms of revenue, the scaffold-based 3D cell culture product segment is anticipated to account for the largest share of the global 3D cell culture market. The growth of the segment can be attributed to several benefits associated with its usage, namely ability to mimic in-vivo conditions, thereby, facilitating wide scale adoption of this technologies among various end users.

3D Cell Culture Market by Application

On the basis of application the 3D cell culture market can be segmented into drug discovery & toxicology, cancer & stem cell research, tissue engineering & regenerative medicine and other applications. The segment of cancer and stem cell research is estimated to account for the largest share of application in the 3D cell culture market, owing to the increasing incidences and prevalence of cancer across the globe.

3D Cell Culture Market by End Users

On the basis of end users segment can be divided into research institutes, pharmaceutical & biotechnology companies and other end users. Increasing investments in the field of R&D, increasing funding from private as well as public sectors and presence of a large number of pharmaceutical and biotechnology companies is estimated to contribute significantly to the dominant market share of this segment.

3D Cell Culture Market by Regions

The global 3D cell culture market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of 3D cell culture, followed by Europe and Asia Pacific. North America will continue to dominate the global 3D cell culture market in the forecast period owing to factors such as highly developed research infrastructure, and presence of private and public funding in the sector of R&D. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, India, and Japan. Factors such as the rising focus of major players in emerging Asian countries, increasing government support and continual growth of the animal testing industry are driving the growth of the 3D cell culture market in this region.

3D Cell Culture Market Prominent Players

The prominent players in the global 3D cell culture market are Corning Incorporated, Thermo Fisher Scientific Inc. , Merck & Co., Inc., Lonza, 3D Biotek LLC., InSphero, REPROCELL USA Inc., Nano3D Biosciences, Inc., SYNTHECON, INCORPORATED and QGel SA, Lausanne, Switzerland.